PortfoliosLab logoPortfoliosLab logo
MOH vs. BRKR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MOH vs. BRKR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Molina Healthcare, Inc. (MOH) and Bruker Corporation (BRKR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MOH achieves a 14.33% return, which is significantly lower than BRKR's 19.60% return. Over the past 10 years, MOH has outperformed BRKR with an annualized return of 14.61%, while BRKR has yielded a comparatively lower 8.96% annualized return.


MOH

1D
3.96%
1M
6.71%
YTD
14.33%
6M
27.59%
1Y
-33.17%
3Y*
-11.30%
5Y*
-4.39%
10Y*
14.61%

BRKR

1D
-0.23%
1M
27.40%
YTD
19.60%
6M
22.49%
1Y
47.68%
3Y*
-8.73%
5Y*
-4.63%
10Y*
8.96%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MOH vs. BRKR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MOH
Molina Healthcare, Inc.
14.33%-40.37%-19.45%9.41%3.82%49.56%56.74%16.75%51.56%41.32%
BRKR
Bruker Corporation
19.60%-19.24%-19.99%7.82%-18.29%55.35%6.58%71.85%-12.82%62.96%

Correlation

The correlation between MOH and BRKR is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.11

Correlation (3Y)
Calculated over the trailing 3-year period

0.22

Correlation (5Y)
Calculated over the trailing 5-year period

0.26

Correlation (10Y)
Calculated over the trailing 10-year period

0.28

Correlation (All Time)
Calculated using the full available price history since Jul 2, 2003

0.29

The correlation between MOH and BRKR shifts across timeframes, from 0.11 (1 year) to 0.29 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

MOH:

$10.12B

BRKR:

$8.59B

EPS

MOH:

$3.59

BRKR:

-$0.17

PS Ratio

MOH:

0.23

BRKR:

2.48

PB Ratio

MOH:

2.48

BRKR:

3.48

Total Revenue (TTM)

MOH:

$45.08B

BRKR:

$3.46B

Gross Profit (TTM)

MOH:

$2.80B

BRKR:

$1.57B

EBITDA (TTM)

MOH:

$617.00M

BRKR:

$224.20M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MOH vs. BRKR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MOH
MOH Risk / Return Rank: 2222
Overall Rank
MOH Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
MOH Sortino Ratio Rank: 2222
Sortino Ratio Rank
MOH Omega Ratio Rank: 2020
Omega Ratio Rank
MOH Calmar Ratio Rank: 2222
Calmar Ratio Rank
MOH Martin Ratio Rank: 2828
Martin Ratio Rank

BRKR
BRKR Risk / Return Rank: 6666
Overall Rank
BRKR Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
BRKR Sortino Ratio Rank: 6666
Sortino Ratio Rank
BRKR Omega Ratio Rank: 6464
Omega Ratio Rank
BRKR Calmar Ratio Rank: 6666
Calmar Ratio Rank
BRKR Martin Ratio Rank: 6464
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MOH vs. BRKR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Molina Healthcare, Inc. (MOH) and Bruker Corporation (BRKR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MOHBRKRDifference
Sharpe ratioReturn per unit of total volatility

-1.43

Sortino ratioReturn per unit of downside risk

-1.89

Omega ratioGain probability vs. loss probability

0.93

1.18

-0.25

Calmar ratioReturn relative to maximum drawdown

-0.56

1.20

-1.76

Martin ratioReturn relative to average drawdown

-0.76

2.33

-3.09

MOH vs. BRKR - Sharpe Ratio Comparison

The current MOH Sharpe Ratio is -0.56, which is lower than the BRKR Sharpe Ratio of 0.87. The chart below compares the historical Sharpe Ratios of MOH and BRKR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


MOHBRKRDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.56

0.87

-1.43

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.11

-0.11

0.00

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.36

0.24

+0.12

Sharpe Ratio (All Time)

Calculated using the full available price history

0.29

0.07

+0.23

Drawdowns

MOH vs. BRKR - Drawdown Comparison

The maximum MOH drawdown since its inception was -70.76%, smaller than the maximum BRKR drawdown of -94.83%. Use the drawdown chart below to compare losses from any high point for MOH and BRKR.


Loading charts...

Drawdown Indicators


MOHBRKRDifference

Max Drawdown

Largest peak-to-trough decline

-70.76%

-94.83%

+24.07%

Max Drawdown (1Y)

Largest decline over 1 year

-59.96%

-39.85%

-20.11%

Max Drawdown (3Y)

Largest decline over 3 years

-70.76%

-68.72%

-2.04%

Max Drawdown (5Y)

Largest decline over 5 years

-70.76%

-68.72%

-2.04%

Max Drawdown (10Y)

Largest decline over 10 years

-70.76%

-68.72%

-2.04%

Current Drawdown

Current decline from peak

-52.71%

-39.79%

-12.92%

Average Drawdown

Average peak-to-trough decline

-24.58%

-57.71%

+33.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

43.74%

20.50%

+23.24%

Volatility

MOH vs. BRKR - Volatility Comparison

The current volatility for Molina Healthcare, Inc. (MOH) is 11.88%, while Bruker Corporation (BRKR) has a volatility of 19.73%. This indicates that MOH experiences smaller price fluctuations and is considered to be less risky than BRKR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MOHBRKRDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.88%

19.73%

-7.85%

Volatility (6M)

Calculated over the trailing 6-month period

43.64%

38.95%

+4.69%

Volatility (1Y)

Calculated over the trailing 1-year period

59.81%

55.25%

+4.56%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

39.88%

41.47%

-1.59%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

40.76%

37.73%

+3.03%

Dividends

MOH vs. BRKR - Dividend Comparison

MOH has not paid dividends to shareholders, while BRKR's dividend yield for the trailing twelve months is around 0.36%.


PositionTTM2025202420232022202120202019201820172016
BRKR
Bruker Corporation
0.36%0.42%0.34%0.27%0.29%0.19%0.30%0.31%0.54%0.47%0.76%
MOH
Molina Healthcare, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

MOH vs. BRKR - Financials Comparison

This section allows you to compare key financial metrics between Molina Healthcare, Inc. and Bruker Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B20222023202420252026
10.80B
823.40M
(MOH) Total Revenue
(BRKR) Total Revenue
Values in USD except per share items

MOH vs. BRKR - Profitability Comparison

The chart below illustrates the profitability comparison between Molina Healthcare, Inc. and Bruker Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%10.0%20.0%30.0%40.0%50.0%202220232024202520260
46.1%
Portfolio components
MOH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Molina Healthcare, Inc. reported a gross profit of 0.00 and revenue of 10.80B. Therefore, the gross margin over that period was 0.0%.

BRKR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bruker Corporation reported a gross profit of 379.80M and revenue of 823.40M. Therefore, the gross margin over that period was 46.1%.

MOH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Molina Healthcare, Inc. reported an operating income of 83.00M and revenue of 10.80B, resulting in an operating margin of 0.8%.

BRKR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bruker Corporation reported an operating income of 10.20M and revenue of 823.40M, resulting in an operating margin of 1.2%.

MOH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Molina Healthcare, Inc. reported a net income of 14.00M and revenue of 10.80B, resulting in a net margin of 0.1%.

BRKR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bruker Corporation reported a net income of 0.00 and revenue of 823.40M, resulting in a net margin of 0.0%.


Frequently Asked Questions


MOH and BRKR have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BRKR has higher volatility (19.73%) compared to MOH (11.88%). In terms of maximum drawdown, MOH dropped -70.76% vs BRKR's -94.83%.

BRKR currently has the higher Sharpe Ratio (0.87 vs -0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MOH and BRKR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer